| 摘要 |
<p>The novel compounds of the general formula <IMAGE> in which Q<1>, together with the nitrogen atom, denotes a group of the formula <2bL>N-CH2CH2- (a) <2bL>N-CH2CH2CH2- (b), <2bL>N-CH=CH- (c), <2bL>N-CH2-CH=CH- (d), <2bL>N-CH2-S(O)p- (e), <2bL>N-CH2CH2-S(O)p- (f) or <2bL>N-CH=CH-S(O)p- (g), p denotes the number 0, 1 or 2, Ra denotes a phenyl, pyridyl or thienyl group which is optionally substituted by halogen, trifluoromethyl, nitro, lower alkyl or lower alkoxy, Rb and Rc, together with the carbon atom marked alpha , denote a group of the formula <2bL>C alpha -S-CH=CH- (h) <2bL>C alpha -CH=CH-S- (i) or <2bL>C alpha CH=CH-CH=CH- (j) which is optionally substituted by halogen, trifluoromethyl, lower alkyl, lower alkoxy, nitro, amino or mono- or di(lower alkyl) amino, and the dashed line denotes an additional bond, are intermediates for the preparation of novel therapeutic active compounds having muscle-relaxing, sedative/hypnotic, anxiolytic and/or anticonvulsive properties.</p> |
